Mankind Pharma has partnered with Innovent Biologics to bring sintilimab, a PD-1 immunotherapy, to India. The drug treats various cancers and improves patient access to innovative therapies. Mankind Pharma will manage registration, import, marketing, and distribution, while Innovent will handle manufacturing and supply. This collaboration aims to transform oncology care in India.
